CME Group FY2027 EPS Estimate Raised by Erste Group Bank

CME Group Inc. (NASDAQ:CME) – Research analysts at Erste Group Bank upped their FY2027 earnings per share estimates for CME Group in a report released on Thursday, June 25th. Erste Group Bank analyst H. Engel now anticipates that the financial services provider will earn $12.96 per share for the year, up from their previous forecast of $12.92. Erste Group Bank has a “Hold” rating on the stock. The consensus estimate for CME Group’s current full-year earnings is $12.28 per share.

Several other equities analysts have also recently issued reports on CME. Piper Sandler set a $320.00 price objective on CME Group in a research note on Wednesday, June 17th. TD Cowen lowered their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. UBS Group reissued an “overweight” rating on shares of CME Group in a report on Monday, June 15th. Morgan Stanley reduced their price target on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. Finally, The Goldman Sachs Group decreased their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday. Twelve investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $300.94.

CME Group Price Performance

Shares of NASDAQ CME opened at $220.83 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $80.02 billion, a price-to-earnings ratio of 18.84, a price-to-earnings-growth ratio of 2.44 and a beta of 0.21. CME Group has a twelve month low of $218.31 and a twelve month high of $329.16. The business has a 50 day simple moving average of $270.24 and a 200-day simple moving average of $285.17.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.80 EPS.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Insiders Place Their Bets

In other news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by insiders.

Institutional Trading of CME Group

Several hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after acquiring an additional 588,509 shares during the period. State Street Corp increased its holdings in shares of CME Group by 0.4% during the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after purchasing an additional 56,725 shares during the period. Norges Bank acquired a new position in shares of CME Group during the fourth quarter valued at $1,523,241,000. Bank of New York Mellon Corp raised its stake in shares of CME Group by 2.8% during the fourth quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock valued at $1,344,776,000 after purchasing an additional 134,242 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of CME Group by 2.8% during the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock valued at $1,300,450,000 after purchasing an additional 130,848 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Director William Shepard bought 325 shares of CME at $230.57, a small insider purchase that can signal confidence in the stock’s longer-term outlook. Insider Buying: CME Group (NASDAQ:CME) Director Purchases 325 Shares
• Positive Sentiment: A recent article highlighted CME as one of several oversold stocks, which may suggest the pullback has pushed the shares into technically attractive territory for some investors. CME Group (CME): 11 Oversold Tech Stocks to Buy Now
• Neutral Sentiment: Analysts expect CME’s next quarterly earnings report to show only low single-digit profit growth, implying steady but not especially strong near-term fundamentals. What to Expect From CME Group’s Next Quarterly Earnings Report
• Neutral Sentiment: A Seeking Alpha note said CME’s recent pullback does not change its hold-style view, suggesting some analysts see the decline as valuation-driven rather than a major change in business fundamentals. CME Group’s Pullback Does Not Change The Rating
• Negative Sentiment: Goldman Sachs lowered its price target on CME and maintained a sell rating, reinforcing a cautious outlook from at least one major Wall Street firm. Goldman Sachs adjusts price target on CME Group
• Negative Sentiment: A market recap said CME was among the financial sector’s losers in the quarter, adding to the tone of recent weakness in the shares. Financial sector climbs in Q2 as Robinhood leads gainers, CME heads losers

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.